Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ae Nim Pae

Showing results (161-170 of 179) with videos related to

Pageof 18
Sort By:
Cancer Letters|April 2, 2018
A novel tropomyosin-related kinase A inhibitor, KK5101 to treat pancreatic cancerZhenghuan Fang, Boreum Han, Kyung Hee Jung, et al.
Neuropharmacology|February 8, 2020
Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson's disease animal modelSiwon Kim, Ambily Nath Indu Viswanath, Jong-Hyun Park, et al.
Journal of Medicinal Chemistry|July 25, 2023
Exploration of Tetrahydroisoquinoline- and Benzo[<i>c</i>]azepine-Based Sphingosine 1-Phosphate Receptor 1 Agonists for the Treatment of Multiple SclerosisEunji Cha, Jushin Kim, Lizaveta Gotina, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 25, 2017
Design, synthesis, biological evaluation and molecular modelling of 2-(2-aryloxyphenyl)-1,4-dihydroisoquinolin-3(2H)-ones: A novel class of TSPO ligands modulating amyloid-β-induced mPTP openingAhmed Elkamhawy, Jung-Eun Park, Ahmed H E Hassan, et al.
Bioorganic Chemistry|September 23, 2019
Optimization study towards more potent thiazolidine-2,4-dione IKK-β modulator: Synthesis, biological evaluation and in silico docking simulationAhmed Elkamhawy, Nam Youn Kim, Ahmed H E Hassan, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2011
Discovery of piperidinyl aminopyrimidine derivatives as IKK-2 inhibitorsSora Kim, Jin Kyo Jung, Hyo Seon Lee, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 27, 2021
Modulation of SETDB1 activity by APQ ameliorates heterochromatin condensation, motor function, and neuropathology in a Huntington's disease mouse modelYu Jin Hwang, Seung Jae Hyeon, Younghee Kim, et al.
Acta Neuropathologica|June 9, 2017
Remodeling of heterochromatin structure slows neuropathological progression and prolongs survival in an animal model of Huntington's diseaseJunghee Lee, Yu Jin Hwang, Yunha Kim, et al.
Angewandte Chemie (International Ed. in English)|December 8, 2023
NeuM: A Neuron-Selective Probe Incorporates into Live Neuronal Membranes via Enhanced Clathrin-Mediated Endocytosis in Primary NeuronsYoonsik Sung, Lizaveta Gotina, Kyu Hyeon Kim, et al.
European Journal of Medicinal Chemistry|March 30, 2013
Novel pyrimidoazepine analogs as serotonin 5-HT(2A) and 5-HT(2C) receptor ligands for the treatment of obesityHa Yun Yang, Jinsung Tae, Yong Wan Seo, et al.
Pageof 18

Showing results (161-170 of 179) with videos related to

Sort By:
Pageof 18
Cancer Letters|April 2, 2018
A novel tropomyosin-related kinase A inhibitor, KK5101 to treat pancreatic cancerZhenghuan Fang, Boreum Han, Kyung Hee Jung, et al.
Neuropharmacology|February 8, 2020
Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson's disease animal modelSiwon Kim, Ambily Nath Indu Viswanath, Jong-Hyun Park, et al.
Journal of Medicinal Chemistry|July 25, 2023
Exploration of Tetrahydroisoquinoline- and Benzo[<i>c</i>]azepine-Based Sphingosine 1-Phosphate Receptor 1 Agonists for the Treatment of Multiple SclerosisEunji Cha, Jushin Kim, Lizaveta Gotina, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 25, 2017
Design, synthesis, biological evaluation and molecular modelling of 2-(2-aryloxyphenyl)-1,4-dihydroisoquinolin-3(2H)-ones: A novel class of TSPO ligands modulating amyloid-β-induced mPTP openingAhmed Elkamhawy, Jung-Eun Park, Ahmed H E Hassan, et al.
Bioorganic Chemistry|September 23, 2019
Optimization study towards more potent thiazolidine-2,4-dione IKK-β modulator: Synthesis, biological evaluation and in silico docking simulationAhmed Elkamhawy, Nam Youn Kim, Ahmed H E Hassan, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2011
Discovery of piperidinyl aminopyrimidine derivatives as IKK-2 inhibitorsSora Kim, Jin Kyo Jung, Hyo Seon Lee, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 27, 2021
Modulation of SETDB1 activity by APQ ameliorates heterochromatin condensation, motor function, and neuropathology in a Huntington's disease mouse modelYu Jin Hwang, Seung Jae Hyeon, Younghee Kim, et al.
Acta Neuropathologica|June 9, 2017
Remodeling of heterochromatin structure slows neuropathological progression and prolongs survival in an animal model of Huntington's diseaseJunghee Lee, Yu Jin Hwang, Yunha Kim, et al.
Angewandte Chemie (International Ed. in English)|December 8, 2023
NeuM: A Neuron-Selective Probe Incorporates into Live Neuronal Membranes via Enhanced Clathrin-Mediated Endocytosis in Primary NeuronsYoonsik Sung, Lizaveta Gotina, Kyu Hyeon Kim, et al.
European Journal of Medicinal Chemistry|March 30, 2013
Novel pyrimidoazepine analogs as serotonin 5-HT(2A) and 5-HT(2C) receptor ligands for the treatment of obesityHa Yun Yang, Jinsung Tae, Yong Wan Seo, et al.
Pageof 18